LexDanaLexDanabeta
Inventor

Rosana Kapeller-Libermann

Inventor
Chestnut Hill, MA, US

Overview

57→
Patents
2000–2019
Patent span
Chemistry
Primary field (CPC C)

Patents· 57 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary
C12NMicroorganisms or enzymes23%
A61KPreparations for medical, dental or toiletry purposes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
C07KPeptides10%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
A01KAnimal husbandry7%
C12YEnzymes7%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
Y02ATechnologies for adaptation to climate change3%
C07CAcyclic or carbocyclic compounds1%
PatentTitleYear
10,300,109Peptidomimetic macrocycles20199,751,892'IRAK inhibitors and uses thereof'20179,458,202'Peptidomimetic macrocycles with improved properties'20169,212,190'IRAK inhibitors and uses thereof'20159,175,007'IRAK inhibitors and uses thereof'20158,808,694'Therapeutic peptidomimetic macrocycles'20148,399,405'Peptidomimetic macrocycles'20138,334,111'Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor'20127,977,059'17867, a novel human aminopeptidase'20117,910,346'Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor'20117,820,403'ACTR-1, a novel human acyltransferase and uses thereof'20107,704,711'Human protein kinases and uses therefor'20107,696,316'21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor'20107,527,962'Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor'20097,485,308'26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor'20097,410,785'ACTR-1, a novel human acyltransferase and uses thereof'20087,351,566'27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552, and 65577 molecules and uses therefor'20087,329,529'Ubiqutin proteases'20087,301,016'Human transferase family members and uses thereof'20077,288,392'Human protein kinases and uses therefor'20077,282,360'Human protein kinase, phosphatase, and protease family members and uses thereof'20077,241,585'14171 protein kinase, a novel human protein kinase and uses thereof'20077,235,634'2786, a novel human aminopeptidase'20077,198,929'14790, a novel protein kinase molecule and uses therefor'20077,198,930'Human protein kinase, phosphatase, and protease family members and uses thereof'20077,094,587'16002 Molecules and uses therefor'20067,081,344'Methods for screening compounds that bind human COE-2'20067,070,947'Human protein kinase, phosphatase, and protease family members and uses thereof'20067,052,888'ACTR-1 a novel human acyltransferase and uses thereof'20067,034,111'17867, a novel human aminopeptidase'20067,001,753'59079 and 12599, protein kinase family members and uses therefor'20066,984,502'Methods and compositions of human 69087 nucleic acids and uses thereof'20066,962,811'14715, a human fringe family member nucleic acids and uses therefor'20056,953,682'Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor'20056,946,274'13245, a novel human myotonic dystrophy type protein kinase and uses therefor'20056,911,335'57316 and 33338, human ubiquitin carboxyl terminal hydrolases and uses therefor'20056,900,044'68999, a human ubiquitin carboxyl-terminal hydrolase family member and uses therefor'20056,864,064'18891, a novel human lipase'20056,864,078'14790, novel protein kinase molecule and uses therefor'20056,797,502'18891, a novel human lipase'20046,730,491'2504, 15977, and 14760, novel protein kinase family members and uses therefor'20046,703,230'47174, a novel human glycosyltransferase and uses thereof'20046,673,564'Methods for using 22045, a human cyclic nucleotide phosphodiesterase'20046,638,721'Human protein kinases and uses therefor'20036,630,335'14171 protein kinase, a novel human protein kinase and uses thereof'20036,620,592'18036, a novel calpain-like protease and uses thereof'20036,607,892'21529, a novel adenylate cyclase'20036,558,936'Human lipase proteins, nucleic acids encoding them, and uses of both of these'20036,451,994'23413, a novel human ubiquitin protease'20026,444,802'Human aminopeptidase'20026,403,358'21529, a novel adenylate cyclase'20026,383,780'2786, a novel human aminopeptidase'20026,369,210'22012, human carboxypeptidase'20026,362,324'17867 a novel human aminopeptidase'20026,337,187'18891, a novel human lipase'20026,329,171'23484, A novel human ubiquitin protease'20016,146,876'22025, a novel human cyclic nucleotide phosphodiesterase'2000

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2000–2012Patents assigned to MILLENNIUM PHARM INC (46)· patent assignee history
2000–2019Based in Chestnut Hill, MA, US· patent location history
2012–2016Patents assigned to KAPELLER-LIBERMANN ROSANA (4)· patent assignee history
2013–2019Patents assigned to AILERON THERAPEUTICS INC (4)· patent assignee history
2013–2016Patents assigned to ANNIS DAVID ALLEN (3)· patent assignee history
2013–2016Patents assigned to KAWAHATA NORIYUKI (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MILLENNIUM PHARM INC462000–2012
AILERON THERAPEUTICS INC42013–2019
KAPELLER-LIBERMANN ROSANAself42012–2016
ANNIS DAVID ALLEN32013–2016
KAWAHATA NORIYUKI32013–2016
Locations
LocationPatentsSpan
Chestnut Hill, Massachusetts, US572000–2019